Sterile Pharmaceutical Manufacturing and Compounding Support

The contract requires the custom sterile compounding of patient-specific total parenteral nutrition formulations, involving the precise blending of amino acids, carbohydrates, lipids, electrolytes, and vitamins under strict aseptic conditions to meet individual patient needs. This work demands adherence to pharmaceutical quality standards and sterile compounding protocols to ensure safety, potency, and consistency in every formulation produced. The contract is classified as a subcontract under NAICS code 325412 and is issued by the Department of Veterans Affairs through the 248-NETWORK Contract Office 8. Although no solicitation number or specific point of contact is provided, the response deadline is set for April 21, 2026, at 4:00 PM, and the posting date is April 24, 2026, indicating a possible administrative discrepancy. The place of performance and organizational details are not specified, leaving the physical location of compounding activities undetermined, but all work must comply with federal pharmaceutical regulations and VA-specific requirements for patient care.